AU2003230301A1 - Antisense modulation of dyrk4 expression - Google Patents
Antisense modulation of dyrk4 expressionInfo
- Publication number
- AU2003230301A1 AU2003230301A1 AU2003230301A AU2003230301A AU2003230301A1 AU 2003230301 A1 AU2003230301 A1 AU 2003230301A1 AU 2003230301 A AU2003230301 A AU 2003230301A AU 2003230301 A AU2003230301 A AU 2003230301A AU 2003230301 A1 AU2003230301 A1 AU 2003230301A1
- Authority
- AU
- Australia
- Prior art keywords
- dyrk4
- expression
- antisense modulation
- antisense
- modulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/144,140 US20030211606A1 (en) | 2002-05-10 | 2002-05-10 | Antisense modulation of DYRK4 expression |
US10/144,140 | 2002-05-10 | ||
PCT/US2003/014409 WO2003095679A1 (en) | 2002-05-10 | 2003-05-09 | Antisense modulation of dyrk4 expression |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003230301A1 true AU2003230301A1 (en) | 2003-11-11 |
Family
ID=29400261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003230301A Abandoned AU2003230301A1 (en) | 2002-05-10 | 2003-05-09 | Antisense modulation of dyrk4 expression |
Country Status (3)
Country | Link |
---|---|
US (1) | US20030211606A1 (en) |
AU (1) | AU2003230301A1 (en) |
WO (1) | WO2003095679A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007525153A (en) * | 2003-02-11 | 2007-09-06 | エクセリクシス, インク. | DYRK as a modifier for APC and AXIN pathways and methods of use |
CN102482672B (en) * | 2009-06-26 | 2016-11-09 | 库尔纳公司 | By suppressing the natural antisense transcript treatment Down syndrome gene-associated diseases of Down syndrome gene |
EP3256591A4 (en) | 2015-02-13 | 2018-08-08 | Translate Bio Ma, Inc. | Hybrid oligonucleotides and uses thereof |
CN107406880A (en) * | 2015-02-24 | 2017-11-28 | 海德堡鲁普雷希特卡尔斯大学 | For detecting the biomarker group of cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965365A (en) * | 1997-03-14 | 1999-10-12 | Incyte Pharmaceuticals, Inc. | Serine/threonine protein kinase |
US5877309A (en) * | 1997-08-13 | 1999-03-02 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides against JNK |
US6100033A (en) * | 1998-04-30 | 2000-08-08 | The Regents Of The University Of California | Diagnostic test for prenatal identification of Down's syndrome and mental retardation and gene therapy therefor |
US6001623A (en) * | 1998-07-31 | 1999-12-14 | Smithkline Beecham Corporation | Human protein kinase H2LAU20 |
-
2002
- 2002-05-10 US US10/144,140 patent/US20030211606A1/en not_active Abandoned
-
2003
- 2003-05-09 AU AU2003230301A patent/AU2003230301A1/en not_active Abandoned
- 2003-05-09 WO PCT/US2003/014409 patent/WO2003095679A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003095679A1 (en) | 2003-11-20 |
US20030211606A1 (en) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003281327A1 (en) | Antisense modulation of tfg-beta 2 expression | |
AU2003237875A1 (en) | Antisense modulation of apolipoprotein b expression | |
AU2002350228A1 (en) | Antisense modulation of myd88 expression | |
AU2003268096A1 (en) | ANTISENSE MODULATION OF Nav1.3 EXPRESSION | |
AU2003239579A1 (en) | Antisense modulation of vegf-c expression | |
AU2002366788A1 (en) | Antisense modulation of ship-1 expression | |
AU2002318139A1 (en) | Antisense modulation of src-c expression | |
AU2003257966A1 (en) | Antisense modulation of lar expression | |
AU2002357102A1 (en) | Antisense modulation of cd36l1 expression | |
AU2003295790A1 (en) | Modulation of iap-like expression | |
AU2003230301A1 (en) | Antisense modulation of dyrk4 expression | |
AU2003241496A1 (en) | Antisense modulation of inhibitor-kappa b kinase-beta expression | |
AU2003261307A1 (en) | Antisense modulation of resistin expression | |
AU2003236510A1 (en) | Antisense modulation of ptpn12 expression | |
AU2003247400A1 (en) | Antisense modulation of ptprk expression | |
AU2002347809A1 (en) | Antisense modulation of inhibitor-kappa b kinase-gamma expression | |
AU2003263836A1 (en) | Antisense modulation of ptpra expression | |
AU2003287180A1 (en) | Antisense modulation of gfat expression | |
AU2003237211A1 (en) | Antisense modulation of vegf-b expression | |
AU2003243589A1 (en) | Antisense modulation of smrt expression | |
AU2003254258A1 (en) | Antisense modulation of edg1 expression | |
EP1578942A3 (en) | ANTISENSE MODULATION OF mitoNEET EXPRESSION | |
AU2003295906A1 (en) | ANTISENSE MODULATION OF mitoNEET EXPRESSION | |
AU2003247701A1 (en) | Antisense modulation of livin expression | |
AU2003251530A1 (en) | Antisense modulation of stati expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 18, NO 2, PAGE(S) 531 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME ISIS PHARMACEUTICALS, INC., APPLICATION NO. 2003230301, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003 |